Vicasinabin (RG7774) is an orally active, selective, and full CB2R agonist, with EC50 values of 2.81 nM and 2.60 nM for human CB2R and mouse CB2R, respectively. Vicasinabin inhibits inflammation, reduces leukocyte adhesion and decreases vascular permeability by selectively activating CB2R. Vicasinabin can be used in the researches for diabetic retinopathy, uveitis and laser-induced choroidal neovascularization[1][2].
Molecular Weight:
358.40
Purity:
98.37
CAS Number:
[1433361-02-4]
Formula:
C15H22N10O
Target:
Cannabinoid Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted